QT Imaging (NASDAQ:QTI – Get Free Report) and Nexeon Medsystems (OTCMKTS:NXNN – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk.
Risk and Volatility
QT Imaging has a beta of -0.1, meaning that its stock price is 110% less volatile than the S&P 500. Comparatively, Nexeon Medsystems has a beta of 6.98, meaning that its stock price is 598% more volatile than the S&P 500.
Profitability
This table compares QT Imaging and Nexeon Medsystems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| QT Imaging | -201.67% | N/A | -184.12% |
| Nexeon Medsystems | N/A | N/A | N/A |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| QT Imaging | $4.88 million | 13.52 | -$8.98 million | ($2.54) | -2.18 |
| Nexeon Medsystems | N/A | N/A | N/A | N/A | N/A |
Nexeon Medsystems has lower revenue, but higher earnings than QT Imaging.
Institutional and Insider Ownership
24.2% of QT Imaging shares are owned by institutional investors. 28.8% of QT Imaging shares are owned by company insiders. Comparatively, 61.2% of Nexeon Medsystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for QT Imaging and Nexeon Medsystems, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| QT Imaging | 1 | 0 | 1 | 0 | 2.00 |
| Nexeon Medsystems | 0 | 0 | 0 | 0 | 0.00 |
Given Nexeon Medsystems’ higher possible upside, analysts plainly believe Nexeon Medsystems is more favorable than QT Imaging.
Summary
Nexeon Medsystems beats QT Imaging on 5 of the 9 factors compared between the two stocks.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
About Nexeon Medsystems
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
